Bispecific antibodies and dual-targeting CAR-T cells for multiple myeloma: latest updates from the 2023 ASCO annual meeting.

Hou, Jiangxue; Li, Yufu; Lin, Quande.

Afiliação

Hou J; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Li Y; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China.
Lin Q; The Affiliated Cancer Hospital of Zhengzhou University & Henan Cancer Hospital, Zhengzhou, 450008, China. zlyylinquande1577@zzu.edu.cn.

Exp Hematol Oncol ; 12(1): 74, 2023 Aug 26.

Article em En | MEDLINE | ID: mdl-37633955